Uscom Ltd (UCM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -7.065x

Based on the latest financial reports, Uscom Ltd (UCM) has a cash flow conversion efficiency ratio of -7.065x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-913.86K USD) by net assets (AU$182.80K ≈ $129.34K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See UCM net asset quality score to measure how much of total assets are equity-financed.

Uscom Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Uscom Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Uscom Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Uscom Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Uscom Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Divio Technologies AB Series B
ST:DIVIO-B
0.255x
Healthcare Triangle Inc
NASDAQ:HCTI
-0.132x
R&R Real Estate Investment Trust
V:RRR-UN
-0.038x
Cell Impact AB
ST:CI
-0.104x
Grand Gulf Energy Ltd
AU:GGE
-0.003x
Oryx International Growth Fund
LSE:OIG
0.003x
Brown Advisory US Smaller Companies PLC
LSE:BASC
-0.002x
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
-0.041x

Annual Cash Flow Conversion Efficiency for Uscom Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Uscom Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Uscom Ltd (UCM) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-38.22K
≈ $-27.05K
AU$-2.71 Million
≈ $-1.92 Million
70.897x +18753.99%
2024-06-30 AU$3.06 Million
≈ $2.17 Million
AU$-1.16 Million
≈ $-823.17K
-0.380x +18.76%
2023-06-30 AU$3.04 Million
≈ $2.15 Million
AU$-1.42 Million
≈ $-1.01 Million
-0.468x -186.98%
2022-06-30 AU$5.94 Million
≈ $4.20 Million
AU$-967.51K
≈ $-684.58K
-0.163x -1012.52%
2021-06-30 AU$3.08 Million
≈ $2.18 Million
AU$54.98K
≈ $38.90K
0.018x +121.59%
2020-06-30 AU$3.42 Million
≈ $2.42 Million
AU$-283.23K
≈ $-200.40K
-0.083x +76.33%
2019-06-30 AU$3.49 Million
≈ $2.47 Million
AU$-1.22 Million
≈ $-862.86K
-0.350x +0.16%
2018-06-30 AU$4.84 Million
≈ $3.43 Million
AU$-1.70 Million
≈ $-1.20 Million
-0.350x -38.97%
2017-06-30 AU$3.78 Million
≈ $2.67 Million
AU$-952.04K
≈ $-673.63K
-0.252x +3.60%
2016-06-30 AU$4.94 Million
≈ $3.49 Million
AU$-1.29 Million
≈ $-913.32K
-0.261x +39.74%
2015-06-30 AU$2.29 Million
≈ $1.62 Million
AU$-992.80K
≈ $-702.47K
-0.434x -16.52%
2014-06-30 AU$3.32 Million
≈ $2.35 Million
AU$-1.24 Million
≈ $-874.36K
-0.372x +9.78%
2013-06-30 AU$2.35 Million
≈ $1.67 Million
AU$-971.58K
≈ $-687.45K
-0.413x +63.38%
2012-06-30 AU$1.47 Million
≈ $1.04 Million
AU$-1.66 Million
≈ $-1.17 Million
-1.127x -60.99%
2011-06-30 AU$3.14 Million
≈ $2.22 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.700x -14.47%
2010-06-30 AU$2.45 Million
≈ $1.73 Million
AU$-1.50 Million
≈ $-1.06 Million
-0.611x -83.86%
2009-06-30 AU$3.06 Million
≈ $2.16 Million
AU$-1.02 Million
≈ $-719.05K
-0.333x +32.24%
2008-06-30 AU$3.41 Million
≈ $2.41 Million
AU$-1.67 Million
≈ $-1.18 Million
-0.491x +17.42%
2007-06-30 AU$5.50 Million
≈ $3.89 Million
AU$-3.27 Million
≈ $-2.31 Million
-0.594x -58.62%
2006-06-30 AU$8.51 Million
≈ $6.02 Million
AU$-3.19 Million
≈ $-2.26 Million
-0.375x -70.02%
2005-06-30 AU$11.75 Million
≈ $8.31 Million
AU$-2.59 Million
≈ $-1.83 Million
-0.220x --

About Uscom Ltd

AU:UCM Australia Medical Devices
Market Cap
$2.21 Million
AU$3.12 Million AUD
Market Cap Rank
#29876 Global
#1738 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.01
All Time High
AU$0.48
About

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more